CLINICAL_TRIALS
trial_result
· 2013-09-30
Clinical Trial Update: Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia [Phase 2]
Summary
A Phase 2 long-term safety and efficacy study of milnacipran in pediatric patients with fibromyalgia was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Primary Fibromyalgia | Phase 2 | Status: TERMINATED | Results posted: 2013-09-30